77832375 - SERACARE

Information

  • Trademark
  • 77832375
  • Serial Number
    77832375
  • Registration Number
    4451588
  • Filing Date
    September 22, 2009
    15 years ago
  • Registration Date
    December 17, 2013
    11 years ago
  • Transaction Date
    April 23, 2024
    a year ago
  • Status Date
    February 21, 2024
    a year ago
  • Published for Opposition Date
    August 30, 2011
    13 years ago
  • Renewal Date
    December 17, 2023
    a year ago
  • Location Date
    February 21, 2024
    a year ago
  • First Use Anywhere Date
    September 26, 2001
    23 years ago
  • First Use In Commerce Date
    September 26, 2001
    23 years ago
  • Status Code
    800
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    JUN, WON KYUNG WENDY
  • Attorney Docket Number
    120776LCL003
    Attorney Name
    Mainak H. Mehta
    Law Office Assigned Location Code
    L30
  • Owners
Mark Drawing Code
4
Mark Identification
SERACARE
Case File Statements
  • GS0051: Diagnostic reagents for medical and veterinary use; Clinical medical reagents; Diagnostic chemicals, reagents or preparations for medical and veterinary use; Chemical reagents for medical and veterinary use; Chemical reagents for pharmaceutical purposes and use in the pharmaceutical industry, namely, chemical reagents for use as diluents and excipients; Testing reagents for medical or clinical use; Genetic testing controls for the testing of human serum, infectious disease antibodies and antigens, and viral nucleic acids, namely, medical diagnostic reagents and assays; Chemical reference materials, namely, quality controls and panels in the nature of human compounds for medical or veterinary use; Chemical reference specimens, namely, serological, viral, genetic and nucleic acid reference specimens in the nature of human serum, infectious disease antibodies and antigens for medical or veterinary use
  • PM0000: SERA CARE
  • CC0000: Color is not claimed as a feature of the mark.
  • TR0010: The wording "SERA" has no meaning in a foreign language.
  • GS0011: Diagnostic chemicals, reagents or preparations for scientific, research or manufacturing use in chemical, pharmaceutical and biotechnology industries; Diagnostic reagents for clinical, medical laboratory or manufacturing use in chemical, pharmaceutical and biotechnology industries; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry, microbiology; Reagents and tools, namely, animal serums, bovine serum albumin, and human blood products, namely, plasma, serum, cells, and human serum albumin, and chromogenic substrates, all for research purposes or manufacturing use in chemical, pharmaceutical and biotechnology industries; Chemical reagents other than for medical or veterinary purposes; Chemical preparations for scientific purposes; Chemical ingredients for use as exipients or diluents in the manufacture of pharmaceuticals; Chemical reagents for reference control, namely, genetic testing controls and controls for the testing of human serum, infectious disease antibodies and antigens, and viral nucleic acids, all for industrial use and not for medical purposes; Chemical solutions in the nature of quality control standard solutions for testing human serum, infectious disease antibodies and antigens, human genetics, and viral nucleic acids, all for industrial use and not for medical purposes; Chemical control serum for scientific or research use in the nature of quality controls for infectious disease and genetic testing; Biochemical control serum for scientific or research use in the nature of quality controls for infectious disease and genetic testing; Biochemical standard serum for scientific or research use; Quality control standard solutions and quality control materials for testing and calibrating medical apparatus and reagents for scientific and research purposes and for clinical or medical laboratory use; Standard serum, control serum, biochemical standard serum, biochemical control serum for scientific and research purposes and for clinical or medical laboratory use
  • GS0421: Custom design and development of chemical reagents and biochemical assays; Providing reagent sample testing for others in the fields of, science and research related thereto; Research support services in the nature of assay development and validation, product development, and report generation, all in the fields of virology, immunological, biological and biochemical research
Case File Event Statements
  • 12/19/2009 - 15 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/25/2009 - 15 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/25/2009 - 15 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/26/2009 - 15 years ago
    3 - NOTICE OF PSEUDO MARK MAILED Type: MPMK
  • 12/18/2009 - 15 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/19/2009 - 15 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/19/2009 - 15 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/29/2010 - 14 years ago
    17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 12/19/2009 - 15 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/19/2009 - 15 years ago
    9 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/19/2009 - 15 years ago
    10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/21/2010 - 14 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/9/2010 - 14 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 7/9/2010 - 14 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/9/2010 - 14 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/29/2010 - 14 years ago
    15 - FINAL REFUSAL WRITTEN Type: CNFR
  • 7/29/2010 - 14 years ago
    16 - FINAL REFUSAL E-MAILED Type: GNFR
  • 2/17/2011 - 14 years ago
    27 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 10/13/2010 - 14 years ago
    18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/31/2011 - 14 years ago
    19 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Type: CPEA
  • 1/31/2011 - 14 years ago
    20 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAP
  • 1/31/2011 - 14 years ago
    21 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAN
  • 2/1/2011 - 14 years ago
    22 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Type: CEPE
  • 2/1/2011 - 14 years ago
    23 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/3/2011 - 14 years ago
    24 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/3/2011 - 14 years ago
    25 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/17/2011 - 14 years ago
    26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/20/2011 - 13 years ago
    37 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/28/2011 - 14 years ago
    28 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 3/15/2011 - 14 years ago
    29 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 3/23/2011 - 14 years ago
    30 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/23/2011 - 14 years ago
    31 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/23/2011 - 14 years ago
    32 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/18/2011 - 13 years ago
    33 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/18/2011 - 13 years ago
    34 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/18/2011 - 13 years ago
    35 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/19/2011 - 13 years ago
    36 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/25/2012 - 12 years ago
    47 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/26/2011 - 13 years ago
    38 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 8/30/2011 - 13 years ago
    39 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/30/2011 - 13 years ago
    40 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/25/2011 - 13 years ago
    41 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/25/2012 - 13 years ago
    42 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/25/2012 - 13 years ago
    44 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/16/2012 - 12 years ago
    45 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 5/16/2012 - 12 years ago
    43 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/17/2012 - 12 years ago
    46 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/6/2013 - 11 years ago
    57 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 10/25/2012 - 12 years ago
    48 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/30/2012 - 12 years ago
    49 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/31/2012 - 12 years ago
    50 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/25/2013 - 12 years ago
    51 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/25/2013 - 12 years ago
    52 - SOU EXTENSION 3 FILED Type: EXT3
  • 5/1/2013 - 11 years ago
    53 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 5/2/2013 - 11 years ago
    54 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/24/2013 - 11 years ago
    55 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 10/24/2013 - 11 years ago
    56 - USE AMENDMENT FILED Type: IUAF
  • 11/12/2013 - 11 years ago
    59 - LAW OFFICE REGISTRATION REVIEW COMPLETED Type: REGV
  • 12/17/2018 - 6 years ago
    62 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 11/11/2013 - 11 years ago
    58 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 11/13/2013 - 11 years ago
    60 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 12/17/2013 - 11 years ago
    61 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/12/2020 - 4 years ago
    63 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 8/10/2020 - 4 years ago
    65 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 8/10/2020 - 4 years ago
    64 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 8/10/2020 - 4 years ago
    66 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 10/5/2022 - 2 years ago
    67 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 12/17/2022 - 2 years ago
    68 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2
  • 8/26/2023 - a year ago
    69 - TEAS SECTION 8 & 9 RECEIVED Type: E89R
  • 2/21/2024 - a year ago
    71 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG
  • 2/21/2024 - a year ago
    72 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1
  • 2/21/2024 - a year ago
    70 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 2/21/2024 - a year ago
    73 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89